7 results match your criteria: "The First Hospital of Handan of Hebei Province[Affiliation]"
Efficacy and safety of yangxinshi versus trimetazidine on exercise tolerance in patients with coronary heart disease after percutaneous coronary intervention: Multicenter, double-blind clinical trial.
Phytomedicine
December 2024
State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China. Electronic address:
Article Synopsis
- The study aimed to investigate the effectiveness and safety of Yangxinshi tablets compared to trimetazidine in enhancing exercise tolerance for coronary heart disease (CHD) patients who had undergone percutaneous coronary intervention (PCI).
- A total of 681 patients were enrolled in a randomized trial, with results showing similar improvements in exercise capacity between the Yangxinshi and trimetazidine groups after 24 weeks, indicating non-inferiority of Yangxinshi.
- Additionally, patients taking Yangxinshi reported significantly greater reductions in depression and anxiety symptoms than those taking trimetazidine, with adverse events being comparable in both groups.
Exploring the relationship between age and prognosis in glioma: rethinking current age stratification.
BMC Neurol
September 2022
Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, People's Republic of China.
Background: The age of glioma plays a unique role in prognosis. We hypothesized that age is not positively correlated with survival prognosis and explored its exact relationship.
Methods: Glioma was identified from the SEER database (between 2000 and 2018).
Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis.
Acta Neurochir (Wien)
August 2022
Department of Cardiology, The First Hospital of Handan of Hebei Province, Handan, 056000, People's Republic of China.
Article Synopsis
- Tumor-treating fields (TTF) is a new cancer treatment approved for recurrent glioblastoma (rGBM) that disrupts tumor cell division using alternating electric fields.
- A meta-analysis evaluated TTF's efficacy and safety, finding a notable improvement in overall survival rates among patients treated with TTF compared to controls.
- It concluded that while TTF is effective, further studies are needed to examine patient characteristics and potential side effects, like skin rashes from the treatment devices.
Ticagrelor for prevention of stroke and cognitive impairment in patients with vascular high-risk factors: A meta-analysis of randomized controlled trials.
Int J Cardiol
April 2022
Department of Cardiology, The First Hospital of Handan of Hebei Province, Handan 056000, People's Republic of China. Electronic address:
Article Synopsis
- A meta-analysis was conducted to evaluate ticagrelor against other antiplatelet treatments in patients at high risk for vascular diseases, including heart and stroke issues.
- It analyzed data from 12 randomized controlled trials involving over 105,000 patients, focusing on adverse stroke events and cognitive function.
- The results suggested that ticagrelor could effectively reduce the risk of strokes and some cognitive disorders, but it might also increase the risk of intracranial hemorrhage, dizziness, and insomnia.
Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database.
Front Oncol
December 2021
Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Introduction: World Health Organization (WHO) Grade III meningioma is a central nervous system tumor with a poor prognosis. In this retrospective cohort study, the authors constructed a nomogram for predicting the prognosis of WHO Grade III meningioma.
Methods: The patients of this nomogram were based on the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2018.
Development and validation of prognostic nomogram in ependymoma: A retrospective analysis of the SEER database.
Cancer Med
September 2021
Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Article Synopsis
- The study aimed to create a prognostic model for predicting 5- and 10-year survival rates in patients with ependymoma (EPN) using data from the SEER database.
- Seven key survival factors (age, gender, morphology, location, size, laterality, and resection) were identified through LASSO regression.
- The resulting nomogram showed moderate accuracy for predicting outcomes, which can help clinicians tailor treatment plans for EPN patients.
Morphological speculation of the MHPD and related clinical projections.
Surg Radiol Anat
August 2021
Department of Hepatobiliary Surgery, General Rocket Hospital of Chinese People's Liberation Army, Beijing, People's Republic of China.
Objective: The concept of mesopancreas has been brought into focus nowadays. Studies on membrane morphology of pancreas are clinically significant in determining an ideal surgical route for a "holy plane". In this paper, we aimed to observe the structure of the peripancreatic membranes and its interactions with adjacent tissues; tentatively put forward the proposition of mesohepatopancreaticoduodenum (MHPD) and explore in depth in surgical local resection.
View Article and Find Full Text PDF